Peptide Legal Status in New Mexico
Standard federal compliance with typical state oversight. New Mexico follows federal compounding regulations with standard Board of Pharmacy oversight. The state has a moderate wellness clinic industry but no additional peptide restrictions.
Key Facts
New Mexico Regulatory Details
Peptide Availability in New Mexico
| Peptide | FDA Status | Evidence | Availability |
|---|---|---|---|
| BPC-157 | Not Approved | C | Standard Access |
| TB-500 (Thymosin Beta-4) | Not Approved | C | Standard Access |
| GHK-Cu | Not Approved | B | Standard Access |
| Ipamorelin | Not Approved | B | Standard Access |
| CJC-1295 | Not Approved | B | Standard Access |
| Sermorelin | Approved | A | Available by Rx |
| Tesamorelin | Approved | A | Available by Rx |
| Bremelanotide (PT-141) | Approved | A | Available by Rx |
| Semaglutide | Approved | A | Available by Rx |
| Tirzepatide | Approved | A | Available by Rx |
| AOD-9604 | Not Approved | C | Standard Access |
| DSIP (Delta Sleep-Inducing Peptide) | Not Approved | D | Standard Access |
| Epithalon (Epitalon) | Not Approved | C | Standard Access |
| Selank | Not Approved | B | Standard Access |
| Semax | Not Approved | B | Standard Access |
| GHRP-2 | Not Approved | B | Standard Access |
| GHRP-6 | Not Approved | B | Standard Access |
| Hexarelin | Not Approved | B | Standard Access |
| Melanotan II | Not Approved | C | Standard Access |
| LL-37 | Not Approved | C | Standard Access |
| Thymalin | Not Approved | C | Standard Access |
| KPV | Not Approved | D | Standard Access |
| Liraglutide | Approved | A | Available by Rx |
| Retatrutide | Not Approved | B | Standard Access |
| Survodutide | Not Approved | B | Standard Access |
Peptides in New Mexico: FAQ
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.